[1] FERREYRO B L, ANGRIMAN F, MUNSHI L, et al.Association of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure:a systematic review and Meta-analysis[J].JAMA, 2020, 324(1):57-67.
[2] KANG B J, KOH Y, LIM C M, et al.Failure of high-flow nasal cannula therapy may delay intubation and increase mortality[J].Intensive Care Med, 2015, 41(4):623-632.
[3] YOSHIDA T, GRIECO D L, BROCHARD L, et al.Patient self-inflicted lung injury and positive end-expiratory pressure for safe spontaneous breathing[J].Curr Opin Crit Care, 2020, 26(1):59-65.
[4] CAIRONI P, CRESSONI M, CHIUMELLO D, et al.Lung opening and closing during ventilation of acute respiratory distress syndrome[J].Am J Respir Crit Care Med, 2010, 181(6):578-586.
[5] 李文哲, 李建, 于湘友.急性呼吸窘迫综合征机械通气中的自主呼吸:兴利除弊[J/OL].中华重症医学电子杂志(网络版), 2019, 5(2):99-103.
[6] PELLEGRINI M, GUDMUNDSSON M, BENCZE R, et al.Expiratory resistances prevent expiratory diaphragm contraction, flow limitation, and lung collapse[J].Am J Respir Crit Care Med, 2020, 201(10):1218-1229.
[7] BHATTACHARYA M, KALLET R H, WARE L B, et al.Negative-pressure pulmonary edema[J].Chest, 2016, 150(4):927-933.
[8] BATTAGLINI D, ROBBA C, BALL L, et al.Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19:a narrative review[J].Br J Anaesth, 2021, 127(3):353-364.
[9] GOLIGHER E C, BROCHARD L J, REID W D, et al.Diaphragmatic myotrauma:a mediator of prolonged ventilation and poor patient outcomes in acute respiratory failure[J].Lancet Respir Med, 2019, 7(1):90-98.
[10] CARTEAUX G, PARFAIT M, COMBET M, et al.Patient-self inflicted lung injury:a practical review[J].J Clin Med, 2021, 10(12):2738.
[11] CARTEAUX G, MILLÁN-GUILARTE T, DE PROST N, et al.Failure of noninvasive ventilation for de novo acute hypoxemic respiratory failure:role of tidal volume[J].Crit Care Med, 2016, 44(2):282-290.
[12] KISS T, BLUTH T, BRAUNE A, et al.Effects of positive end-expiratory pressure and spontaneous breathing activity on regional lung inflammation in experimental acute respiratory distress syndrome[J].Crit Care Med, 2019, 47(4):e358-e365.
[13] SANG L, ZHAO Z, YUN P J, et al.Qualitative and quantitative assessment of pendelluft:a simple method based on electrical impedance tomography[J].Ann Transl Med, 2020, 8(19):1216.
[14] WYSZOGRODSKI I, KYEI-ABOAGYE K, TAEUSCH H W JR, et al.Surfactant inactivation by hyperventilation:conservation by end-expiratory pressure[J].J Appl Physiol, 1975, 38(3):461-466.
[15] MASCHERONI D, KOLOBOW T, FUMAGALLI R, et al.Acute respiratory failure following pharmacologically induced hyperventilation:an experimental animal study[J].Intensive Care Med, 1988, 15(1):8-14.
[16] TONELLI R, FANTINI R, TABBÌ L, et al.Early inspiratory effort assessment by esophageal manometry predicts noninvasive ventilation outcome in de novo respiratory failure.A Pilot Study[J].Am J Respir Crit Care Med, 2020, 202(4):558-567.
[17] SPINELLI E, MAURI T, BEITLER J R, et al.Respiratory drive in the acute respiratory distress syndrome:pathophysiology, monitoring, and therapeutic interventions[J].Intensive Care Med, 2020, 46(4):606-618.
[18] COURCELLE R, GAUDRY S, SERCK N, et al.Neuromuscular blocking agents(NMBA) for COVID-19 acute respiratory distress syndrome:a multicenter observational study[J].Crit Care, 2020, 24(1):446.
[19] CHANQUES G, CONSTANTIN J M, DEVLIN J W, et al.Analgesia and sedation in patients with ARDS[J].Intensive Care Med, 2020, 46(12):2342-2356.
[20] SUN Y H, DAI B, PENG Y, et al.Factors affecting FiO2 and PEEP during high-flow nasal cannula oxygen therapy:a bench study[J].Clin Respir J, 2019, 13(12):758-764.
[21] BRÄUNLICH J, MAUERSBERGER F, WIRTZ H.Effectiveness of nasal high flow in hypercapnic COPD patients is flow and leakage dependent[J].BMC Pulm Med, 2018, 18(1):14.
[22] MAURI T, SPINELLI E, PAVLOVSKY B, et al.Respiratory drive in patients with sepsis and septic shock:modulation by high-flow nasal cannula[J].Anesthesiology, 2021, 135(6):1066-1075.
[23] ZHANG R, HE H, YUN L, et al.Effect of postextubation high-flow nasal cannula therapy on lung recruitment and overdistension in high-risk patient[J].Crit Care, 2020, 24(1):82.
[24] ARTAUD-MACARI E, BUBENHEIM M, LE BOUAR G, et al.High-flow oxygen therapy versus noninvasive ventilation:a randomised physiological crossover study of alveolar recruitment in acute respiratory failure[J/OL].ERJ Open Res, 2021, 7(4):00373-2021.doi:10.1183/23120541.00373-2021.
[25] FRAT J P, THILLE A W, MERCAT A, et al.High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure[J].N Engl J Med, 2015, 372(23):2185-2196.
[26] ROCHWERG B, EINAV S, CHAUDHURI D, et al.The role for high flow nasal cannula as a respiratory support strategy in adults:a clinical practice guideline[J].Intensive Care Med, 2020, 46(12):2226-2237.
[27] MACINTYRE N R.Physiologic effects of noninvasive ventilation[J].Respir Care, 2019, 64(6):617-628.
[28] DEMOULE A, GIROU E, RICHARD J C, et al.Benefits and risks of success or failure of noninvasive ventilation[J].Intensive Care Med, 2006, 32(11):1756-1765.
[29] MORAIS C C A, KOYAMA Y, YOSHIDA T, et al.High positive end-expiratory pressure renders spontaneous effort noninjurious[J].Am J Respir Crit Care Med, 2018, 197(10):1285-1296.
[30] REZOAGLI E, VILLA S, GATTI S, et al.Helmet and face mask for non-invasive respiratory support in patients with acute hypoxemic respiratory failure:a retrospective study[J].J Crit Care, 2021, 65:56-61.
[31] ADI O, VIA G, SALLEH S H, et al.Randomized clinical trial comparing helmet continuous positive airway pressure(hCPAP) to facemask continuous positive airway pressure(fCPAP) for the treatment of acute respiratory failure in the emergency department[J].Am J Emerg Med, 2021, 49:385-392.
[32] TACCONE P, HESS D, CAIRONI P, et al.Continuous positive airway pressure delivered with a "helmet":effects on carbon dioxide rebreathing[J].Crit Care Med, 2004, 32(10):2090-2096.
[33] GRIECO D L, MENGA L S, RAGGI V, et al.Physiological comparison of high-flow nasal cannula and helmet noninvasive ventilation in acute hypoxemic respiratory failure[J].Am J Respir Crit Care Med, 2020, 201(3):303-312.
[34] GRIECO D L, MENGA L S, CESARANO M, et al.Effect of helmet noninvasive ventilation vs. high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory failure:the henivot randomized clinical trial[J].JAMA, 2021, 325(17):1731-1743.
[35] ROCA O, MESSIKA J, CARALT B, et al.Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure:the utility of the ROX index[J].J Crit Care, 2016, 35:200-205.
[36] ROCA O, CARALT B, MESSIKA J, et al.An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy[J].Am J Respir Crit Care Med, 2019, 199(11):1368-1376.
[37] DUAN J, HAN X, BAI L, et al.Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients[J].Intensive Care Med, 2017, 43(2):192-199.
[38] INNOCENTI F, GIORDANO L, GUALTIERI S, et al.Prediction of mortality with the use of noninvasive ventilation for acute respiratory failure[J].Respir Care, 2020, 65(12):1847-1856. |
